1 |
Markus JV, Vähä-Koskela B, Heikkilä JE and Hinkkanen AE. Oncolytic viruses in cancer therapy, Cancer Letters 2007; 254(2): 178-216
DOI
ScienceOn
|
2 |
Raper SE, Yudkoff M, Chirmule N, Gao GP, Nunes F, Haskal ZJ, Furth EE, Propert KJ, Robinson MB, Magosin S, Simoes H, Speicher L, Hughes J, Tazelaar J, Wivel NA, Wilson JM and Batshaw ML. A pilot study of in vivo liver-directed gene transfer with an adenoviral vector in partial ornithine transcarbamylase deficiency. Human Gene Ther 2002; 13(1): 163-175
DOI
ScienceOn
|
3 |
Raper SE. Gene therapy: The good, the bad, and the ugly, Surgery 2005; 137(5): 487-492
DOI
PUBMED
ScienceOn
|
4 |
Zhang Y, Chirmule N, Gao GP, Qian R, Croyle M, Joshi B, Tazelaar J and Wilson JM. Acute cytokine response to systemic adenoviral vectors in mice is mediated by dendritic cells and macrophages, Mol Ther 2001; 3(51): 697-707
DOI
|
5 |
Krebs P, Scandella E, Odermatt B and Ludewig B. Rapid functional exhaustion and deletion of CTL following immunization with recombinant adenovirus, J Immunol 2005; 174: 4559-4566
DOI
PUBMED
|
6 |
Tripathy SK, Goldwasser MM, Lu EB and Leiden JM. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus, Proc Natl Acad Sci USA 1994; 91: 11557-11561
DOI
ScienceOn
|
7 |
Morrissey RE, Horvath C, Snyder EA, Patrick J and Mac- Donald JS. Rodent nonclinical safety evaluation studies of SCH 58500, an adenoviral vector for the p53 gene, Toxicol Sciences 2002b; 65(2): 266-275
DOI
ScienceOn
|
8 |
Manickan E, Smith JS, Tian Jie, Eggerman TL, Lozier JN, Muller J and Byrnes AP. Rapid Kupffer cell death after intravenous injection of adenovirus vectors, Mol Ther 2006; 13(1): 108-117
DOI
ScienceOn
|
9 |
Morrissey RE, Horvath C, Snyder EA, Patrick J, Collins N, Evans E and MacDonald JS. Porcine toxicology studies of SCH 58500, an adenoviral vector for the p53 gene, Toxicol Sciences 2002a; 65(2): 256-265
DOI
ScienceOn
|
10 |
Pearson S, Jia H and Kandachi K. China approves first gene therapy. Nat Biotechnol 2004; 22(1): 3-4
DOI
ScienceOn
|
11 |
Fechner H, Haack A, Wang H, Wang X, Eizema K, Pauschinger M, Schoemaker R, Veghel R, Houtsmuller A, Schultheiss HP, Lamers J and Poller W. Expression of coxsackie adenovirus receptor and alphav-integrin does not correlate with adenovector targeting in vivo indicating anatomical vector barriers, Gene Ther 1999; 6: 1520-1535
DOI
ScienceOn
|
12 |
Wickham TJ, Mathias P, Cheresh DA and Nemerow G. Integrins and promote adenovirus internalization but not virus attachment, Cell 1993; 73: 309-319
DOI
ScienceOn
|
13 |
Boquet MP, Wonganan P, Dekker JD, Croyle MA. Influence of method of systemic administration of adenovirus on virusmediated toxicity: focus on mortality, virus distribution, and drug metabolism, J Pharmacol Toxicol Methods 2008; 58(3): 222-232
DOI
ScienceOn
|
14 |
McConnell MJ and Imperiale MJ. Biology of adenovirus and its use as a vector for gene therapy, Human Gene Ther 2004; 15(11): 1022-1033
DOI
ScienceOn
|
15 |
Vlachaki MT, Hernandez-Garcia A, Ittmann M, Chhikara M, Aguilar LK, Zhu X, The BS, Butler EB, Woo S, Thompson TC, Barrera-Saldana H and guilar-Cordova E. Impact of preimmunization on adenoviral vector expression and toxicity in a subcutaneous mouse cancer model, Mol Ther 2002; 6: 342-348
DOI
ScienceOn
|
16 |
Raki M, Kanerva A, Ristimaki A, Desmond RA, Chen TD, Ranki T, Sarkioja M, Kangasniemi L and Hemminki A. Combination of gemcitabine and Ad5/3-Delta24, a tropism modified conditionally replicating adenovirus, for the treatment of ovarian cancer, Gene Ther 2005; 12: 1198-1205
DOI
ScienceOn
|
17 |
Su C, Cao H, Tan S, Huang Y, Jia X JL, Wang K, Chen Y, Long J, Liu X, Wu M, Wu X and Qian Q. Toxicology profiles of a novel p53-armed replication-competent oncolytic adenovirus in rodents, felids, and nonhuman primates, Toxicol Sciences 2008; 106(1): 242-250
DOI
ScienceOn
|
18 |
Dewey RA, Morrissey G, Cowsill CM, Stone D, Bolognani F, Dodd NJ, Southgate TD, Klatzmann D, Lassmann H, Castro MG and Lowenstein PR. Chronic brain inflammation and persistent herpes simplex virus 1 thymidine kinase expression in survivors of syngeneic glioma treated by adenovirus-mediated gene therapy: implications for clinical trials, Nat Med 1999; 5: 1256-1263
DOI
ScienceOn
|
19 |
Dormond E, Perrier M and Kamen A. From the first to the third generation adenoviral vector: What parameters are governing the production yield? Biotechnol Advances 2009; 27(2): 133-144
DOI
ScienceOn
|
20 |
Bergelson JM, Cunningham JA, Droguett G, Kurt-Jones EA, Krithivas A, Hong JS, Horwitz MS, Crowell RL and Finberg RW. Isolation of a common receptor for cosackie B viruses and adenoviruses 2 and 5, Science 1997; 275 (5304): 1320-1323
DOI
PUBMED
|
21 |
Thomas CE, Birkett D, Anozie I, Castro MG and Lowenstein PR. Acute direct adenoviral vector cytotoxicity and chronic, but not acute, inflammatory responses correlate with decreased vector-mediated transgene expression in the brain, Mol Ther 2001; 3(1): 36-46
DOI
ScienceOn
|
22 |
Massari I, Donnini A, Argentati K, Straino S, Mangoni A, Gaetano C, Viticchi C, Capogrossi M and Provinciali M. Age-dependent effects of repeated immunization with a first generation adenovirus vector on the immune response and transgene expression in young and old rats, Exp Gerontol 2002; 37: 823-831
DOI
ScienceOn
|
23 |
Driesse MJ, Vincent AJ, Sillevis Smitt PA, Kros JM, Hoogerbrugge PM, Avezaat CJ, Valerio D and Bout A. Intracerebral injection of adenovirus harboring the HSVtk gene combined with ganciclovir administration: toxicity study in nonhuman primates, Gene Ther 1998; 5: 1122-1129
DOI
ScienceOn
|
24 |
Gomez-Manzano C, Yung WK, Alemany R and Fueyo J. Genetically modified adenoviruses against gliomas: from bench to bedside, Neurol 2004; 63: 418-426
DOI
ScienceOn
|
25 |
Garcia-Banuelos J, Siller-Lopez F, Miranda A, Aguilar LK, Aguilar-Cordova E and Armendariz-Borunda J. Cirrhotic rat livers with extensive fibrosis can be safely transduced with clinical-grade adenoviral vectors. Evidence of cirrhosis reversion, Gene Ther 2002; 9: 127-134
DOI
ScienceOn
|
26 |
Raper SE, Chirmule N, Lee FS, Wivel NA, Bagg A, Gao G, Wilson JM and Batshaw ML. Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer, Mol Genet Met 2003; 80(1-2): 148-158
DOI
ScienceOn
|